AstraZeneca signs MOU with NHS

AstraZeneca plc (LSE:AZN; NYSE:AZN) signed a memorandum of understanding with NHS's Health and Social Care Information Centre to study the role of drugs in patients with chronic diseases in the U.K. The partners will initially look at how anonymized data can be used to identify clinical needs in diabetes patients in the U.K. AstraZeneca said the parties are determining their specific roles and responsibilities, but declined to disclose details. ...